

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of inclusion body assembly (GO:0090084) | 7.64193385 |
| 2 | auditory behavior (GO:0031223) | 7.34469946 |
| 3 | neurotransmitter-gated ion channel clustering (GO:0072578) | 6.40391866 |
| 4 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 6.39539196 |
| 5 | cilium or flagellum-dependent cell motility (GO:0001539) | 6.36003387 |
| 6 | mechanosensory behavior (GO:0007638) | 5.56974252 |
| 7 | response to auditory stimulus (GO:0010996) | 4.98600248 |
| 8 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 4.97624742 |
| 9 | positive regulation of growth hormone secretion (GO:0060124) | 4.89628726 |
| 10 | leukocyte tethering or rolling (GO:0050901) | 4.82515775 |
| 11 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.56089121 |
| 12 | cilium movement (GO:0003341) | 4.55234131 |
| 13 | retinal cone cell development (GO:0046549) | 4.52640285 |
| 14 | behavioral response to nicotine (GO:0035095) | 4.43403666 |
| 15 | epithelial cilium movement (GO:0003351) | 4.38141202 |
| 16 | transcytosis (GO:0045056) | 4.18989455 |
| 17 | regulation of inclusion body assembly (GO:0090083) | 4.13833813 |
| 18 | regulation of synapse structural plasticity (GO:0051823) | 4.13532018 |
| 19 | dendritic spine morphogenesis (GO:0060997) | 4.13495495 |
| 20 | retinal rod cell development (GO:0046548) | 4.12547965 |
| 21 | kidney morphogenesis (GO:0060993) | 4.11207443 |
| 22 | vocalization behavior (GO:0071625) | 4.04063504 |
| 23 | lymphangiogenesis (GO:0001946) | 4.02422025 |
| 24 | heart trabecula morphogenesis (GO:0061384) | 4.01603746 |
| 25 | negative regulation of actin filament bundle assembly (GO:0032232) | 4.01359323 |
| 26 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 3.82017560 |
| 27 | heme transport (GO:0015886) | 3.81217780 |
| 28 | blood vessel maturation (GO:0001955) | 3.76689185 |
| 29 | protein localization to synapse (GO:0035418) | 3.73068414 |
| 30 | L-ascorbic acid metabolic process (GO:0019852) | 3.70207967 |
| 31 | motile cilium assembly (GO:0044458) | 3.63672357 |
| 32 | neuron remodeling (GO:0016322) | 3.58638649 |
| 33 | mitotic cell cycle arrest (GO:0071850) | 3.57074610 |
| 34 | nephron epithelium morphogenesis (GO:0072088) | 3.55746267 |
| 35 | nephron tubule morphogenesis (GO:0072078) | 3.55746267 |
| 36 | neuronal stem cell maintenance (GO:0097150) | 3.54561343 |
| 37 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.46393808 |
| 38 | negative regulation of blood vessel endothelial cell migration (GO:0043537) | 3.45184816 |
| 39 | leukotriene biosynthetic process (GO:0019370) | 3.43860227 |
| 40 | axoneme assembly (GO:0035082) | 3.42725299 |
| 41 | mRNA transcription from RNA polymerase II promoter (GO:0042789) | 3.42372980 |
| 42 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 3.41867697 |
| 43 | embryonic heart tube development (GO:0035050) | 3.41856962 |
| 44 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.41092919 |
| 45 | endoderm formation (GO:0001706) | 3.39016539 |
| 46 | brain morphogenesis (GO:0048854) | 3.38355401 |
| 47 | neuron maturation (GO:0042551) | 3.28908904 |
| 48 | cellular response to exogenous dsRNA (GO:0071360) | 3.26041006 |
| 49 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.25324018 |
| 50 | regulation of growth hormone secretion (GO:0060123) | 3.24769003 |
| 51 | notochord development (GO:0030903) | 3.23936942 |
| 52 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.18840530 |
| 53 | endothelial cell differentiation (GO:0045446) | 3.17114537 |
| 54 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.16759897 |
| 55 | positive regulation of Rap GTPase activity (GO:0032854) | 3.15954291 |
| 56 | endothelial cell chemotaxis (GO:0035767) | 3.10565422 |
| 57 | regulation of endothelial cell differentiation (GO:0045601) | 3.07648375 |
| 58 | regulation of dopamine secretion (GO:0014059) | 3.07277807 |
| 59 | primary amino compound metabolic process (GO:1901160) | 2.98707671 |
| 60 | regulation of establishment of cell polarity (GO:2000114) | 2.95857878 |
| 61 | axonemal dynein complex assembly (GO:0070286) | 2.95496497 |
| 62 | iron coordination entity transport (GO:1901678) | 2.95419098 |
| 63 | negative regulation of oligodendrocyte differentiation (GO:0048715) | 2.95108881 |
| 64 | trabecula morphogenesis (GO:0061383) | 2.88910933 |
| 65 | cysteine metabolic process (GO:0006534) | 2.88228567 |
| 66 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.86787548 |
| 67 | growth hormone secretion (GO:0030252) | 2.86245112 |
| 68 | phenol-containing compound catabolic process (GO:0019336) | 2.86191217 |
| 69 | transmission of nerve impulse (GO:0019226) | 2.85414899 |
| 70 | ventricular trabecula myocardium morphogenesis (GO:0003222) | 2.85159338 |
| 71 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.83825637 |
| 72 | photoreceptor cell maintenance (GO:0045494) | 2.82984681 |
| 73 | positive regulation of insulin-like growth factor receptor signaling pathway (GO:0043568) | 2.79668771 |
| 74 | cardiac septum development (GO:0003279) | 2.77581633 |
| 75 | regulation of timing of cell differentiation (GO:0048505) | 2.74935605 |
| 76 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.74192975 |
| 77 | inactivation of MAPK activity (GO:0000188) | 2.73846549 |
| 78 | membrane repolarization during action potential (GO:0086011) | 2.72657296 |
| 79 | neuronal action potential (GO:0019228) | 2.70515660 |
| 80 | chaperone-mediated protein complex assembly (GO:0051131) | 2.70033225 |
| 81 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.68986117 |
| 82 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 2.67769141 |
| 83 | positive regulation of microtubule polymerization or depolymerization (GO:0031112) | 2.67372485 |
| 84 | renal tubule morphogenesis (GO:0061333) | 2.67269397 |
| 85 | protein refolding (GO:0042026) | 2.66851990 |
| 86 | regulation of Rap GTPase activity (GO:0032317) | 2.65861007 |
| 87 | dopamine biosynthetic process (GO:0042416) | 2.64409416 |
| 88 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 2.63314439 |
| 89 | regulation of cardioblast proliferation (GO:0003264) | 2.63314439 |
| 90 | serotonin metabolic process (GO:0042428) | 2.61913386 |
| 91 | ventricular septum development (GO:0003281) | 2.60595094 |
| 92 | alanine transport (GO:0032328) | 2.56759671 |
| 93 | microglial cell activation (GO:0001774) | 2.56687343 |
| 94 | radial glial cell differentiation (GO:0060019) | 2.56004892 |
| 95 | negative regulation of endothelial cell migration (GO:0010596) | 2.55780930 |
| 96 | negative regulation of neurotransmitter transport (GO:0051589) | 2.55224298 |
| 97 | snRNA processing (GO:0016180) | 2.52287270 |
| 98 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.51377933 |
| 99 | forebrain neuron differentiation (GO:0021879) | 2.50854365 |
| 100 | mRNA transcription (GO:0009299) | 2.49922290 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 5.18669075 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.82411842 |
| 3 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.60078099 |
| 4 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.54194443 |
| 5 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 3.06306157 |
| 6 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.83809450 |
| 7 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.78085840 |
| 8 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.45935785 |
| 9 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.18709928 |
| 10 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.15877788 |
| 11 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 2.07181462 |
| 12 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.04184603 |
| 13 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.00720643 |
| 14 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.99309275 |
| 15 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.97941593 |
| 16 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.95781860 |
| 17 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.88369068 |
| 18 | VDR_22108803_ChIP-Seq_LS180_Human | 1.87851674 |
| 19 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.82749532 |
| 20 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.69760976 |
| 21 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.69529787 |
| 22 | TP53_16413492_ChIP-PET_HCT116_Human | 1.68913570 |
| 23 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.65307968 |
| 24 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.59731165 |
| 25 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.58391101 |
| 26 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.55122002 |
| 27 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.55122002 |
| 28 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.54908336 |
| 29 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.52270644 |
| 30 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.50964967 |
| 31 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.48719545 |
| 32 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.43882765 |
| 33 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.43120721 |
| 34 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.43071574 |
| 35 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.42904245 |
| 36 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.40613829 |
| 37 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.40162492 |
| 38 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.39321034 |
| 39 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.37059052 |
| 40 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.33009409 |
| 41 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.32583968 |
| 42 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.32397318 |
| 43 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.32397318 |
| 44 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.32397318 |
| 45 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.32263014 |
| 46 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.30502614 |
| 47 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.30374864 |
| 48 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.29666866 |
| 49 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.29153323 |
| 50 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.28260210 |
| 51 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.26545741 |
| 52 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.26335065 |
| 53 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.24019043 |
| 54 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.21407334 |
| 55 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.20990395 |
| 56 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.19789008 |
| 57 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.19363754 |
| 58 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.14778862 |
| 59 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.12507832 |
| 60 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.10146734 |
| 61 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.09232436 |
| 62 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.07826350 |
| 63 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.07181686 |
| 64 | GATA1_19941826_ChIP-Seq_K562_Human | 1.05620425 |
| 65 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.05583333 |
| 66 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.04134235 |
| 67 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.03738836 |
| 68 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.02422857 |
| 69 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.01937047 |
| 70 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01202533 |
| 71 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.01202533 |
| 72 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.00763844 |
| 73 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.98978101 |
| 74 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.98079054 |
| 75 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.97632835 |
| 76 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.97257995 |
| 77 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.97219047 |
| 78 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.96409314 |
| 79 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.95914940 |
| 80 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.94813210 |
| 81 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.94541307 |
| 82 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.93816598 |
| 83 | STAT3_23295773_ChIP-Seq_U87_Human | 0.93284821 |
| 84 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.92755029 |
| 85 | P300_19829295_ChIP-Seq_ESCs_Human | 0.92227611 |
| 86 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.91729267 |
| 87 | RXR_22108803_ChIP-Seq_LS180_Human | 0.91308977 |
| 88 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.89749197 |
| 89 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.89571673 |
| 90 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.89122518 |
| 91 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.87758997 |
| 92 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.86437120 |
| 93 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.86254359 |
| 94 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.85755085 |
| 95 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.84121739 |
| 96 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.83335296 |
| 97 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.83233603 |
| 98 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.80790708 |
| 99 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.80790708 |
| 100 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.80643777 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005409_darkened_coat_color | 4.04456616 |
| 2 | MP0003878_abnormal_ear_physiology | 3.82170858 |
| 3 | MP0005377_hearing/vestibular/ear_phenot | 3.82170858 |
| 4 | MP0001879_abnormal_lymphatic_vessel | 3.80779623 |
| 5 | MP0005084_abnormal_gallbladder_morpholo | 3.64984508 |
| 6 | MP0002653_abnormal_ependyma_morphology | 2.98262893 |
| 7 | MP0002928_abnormal_bile_duct | 2.71402911 |
| 8 | MP0001968_abnormal_touch/_nociception | 2.46344911 |
| 9 | MP0004147_increased_porphyrin_level | 2.38578684 |
| 10 | MP0005551_abnormal_eye_electrophysiolog | 2.34979017 |
| 11 | MP0001485_abnormal_pinna_reflex | 2.24549496 |
| 12 | MP0005423_abnormal_somatic_nervous | 2.19988466 |
| 13 | MP0003136_yellow_coat_color | 2.10150292 |
| 14 | MP0002735_abnormal_chemical_nociception | 2.08099609 |
| 15 | MP0002102_abnormal_ear_morphology | 2.03377028 |
| 16 | MP0004043_abnormal_pH_regulation | 1.91759257 |
| 17 | MP0004270_analgesia | 1.91513882 |
| 18 | MP0001501_abnormal_sleep_pattern | 1.90844183 |
| 19 | MP0003959_abnormal_lean_body | 1.90022052 |
| 20 | MP0000537_abnormal_urethra_morphology | 1.87284413 |
| 21 | MP0001986_abnormal_taste_sensitivity | 1.86025857 |
| 22 | MP0008872_abnormal_physiological_respon | 1.83371251 |
| 23 | MP0005085_abnormal_gallbladder_physiolo | 1.75001221 |
| 24 | MP0002733_abnormal_thermal_nociception | 1.71998870 |
| 25 | MP0002067_abnormal_sensory_capabilities | 1.70987947 |
| 26 | MP0002009_preneoplasia | 1.63601783 |
| 27 | MP0002163_abnormal_gland_morphology | 1.62880288 |
| 28 | MP0002138_abnormal_hepatobiliary_system | 1.62729499 |
| 29 | MP0001486_abnormal_startle_reflex | 1.59741468 |
| 30 | MP0009745_abnormal_behavioral_response | 1.59093878 |
| 31 | MP0009046_muscle_twitch | 1.52747089 |
| 32 | MP0002734_abnormal_mechanical_nocicepti | 1.50261722 |
| 33 | MP0002064_seizures | 1.48861427 |
| 34 | MP0005167_abnormal_blood-brain_barrier | 1.44359843 |
| 35 | MP0005083_abnormal_biliary_tract | 1.41864351 |
| 36 | MP0000767_abnormal_smooth_muscle | 1.41546558 |
| 37 | MP0001664_abnormal_digestion | 1.39569281 |
| 38 | MP0004924_abnormal_behavior | 1.36557915 |
| 39 | MP0005386_behavior/neurological_phenoty | 1.36557915 |
| 40 | MP0003183_abnormal_peptide_metabolism | 1.36037745 |
| 41 | MP0004142_abnormal_muscle_tone | 1.35104381 |
| 42 | MP0000750_abnormal_muscle_regeneration | 1.35054343 |
| 43 | MP0002089_abnormal_postnatal_growth/wei | 1.34731560 |
| 44 | MP0001440_abnormal_grooming_behavior | 1.31611513 |
| 45 | MP0002277_abnormal_respiratory_mucosa | 1.29247980 |
| 46 | MP0002736_abnormal_nociception_after | 1.28612375 |
| 47 | MP0001970_abnormal_pain_threshold | 1.27807062 |
| 48 | MP0003137_abnormal_impulse_conducting | 1.24574551 |
| 49 | MP0000631_abnormal_neuroendocrine_gland | 1.24473531 |
| 50 | MP0000026_abnormal_inner_ear | 1.23965712 |
| 51 | MP0001188_hyperpigmentation | 1.22393387 |
| 52 | MP0001963_abnormal_hearing_physiology | 1.18744134 |
| 53 | MP0005195_abnormal_posterior_eye | 1.18651887 |
| 54 | MP0003635_abnormal_synaptic_transmissio | 1.18148289 |
| 55 | MP0010386_abnormal_urinary_bladder | 1.14816715 |
| 56 | MP0004133_heterotaxia | 1.12423256 |
| 57 | MP0000516_abnormal_urinary_system | 1.10659216 |
| 58 | MP0005367_renal/urinary_system_phenotyp | 1.10659216 |
| 59 | MP0001324_abnormal_eye_pigmentation | 1.10590295 |
| 60 | MP0008877_abnormal_DNA_methylation | 1.10568968 |
| 61 | MP0002572_abnormal_emotion/affect_behav | 1.09071167 |
| 62 | MP0000343_altered_response_to | 1.08402857 |
| 63 | MP0005248_abnormal_Harderian_gland | 1.08273694 |
| 64 | MP0002272_abnormal_nervous_system | 1.07786064 |
| 65 | MP0000778_abnormal_nervous_system | 1.07375483 |
| 66 | MP0001851_eye_inflammation | 1.03466234 |
| 67 | MP0003638_abnormal_response/metabolism_ | 1.03321400 |
| 68 | MP0003567_abnormal_fetal_cardiomyocyte | 1.01871390 |
| 69 | MP0008058_abnormal_DNA_repair | 1.01066750 |
| 70 | MP0005253_abnormal_eye_physiology | 0.99621628 |
| 71 | MP0002063_abnormal_learning/memory/cond | 0.98222594 |
| 72 | MP0009053_abnormal_anal_canal | 0.95966395 |
| 73 | MP0003943_abnormal_hepatobiliary_system | 0.95929621 |
| 74 | MP0004742_abnormal_vestibular_system | 0.94223279 |
| 75 | MP0002557_abnormal_social/conspecific_i | 0.93044643 |
| 76 | MP0008961_abnormal_basal_metabolism | 0.88957060 |
| 77 | MP0005379_endocrine/exocrine_gland_phen | 0.85512874 |
| 78 | MP0002405_respiratory_system_inflammati | 0.83831261 |
| 79 | MP0005646_abnormal_pituitary_gland | 0.82499497 |
| 80 | MP0005666_abnormal_adipose_tissue | 0.81638493 |
| 81 | MP0003279_aneurysm | 0.81569220 |
| 82 | MP0001502_abnormal_circadian_rhythm | 0.81563380 |
| 83 | MP0010368_abnormal_lymphatic_system | 0.81139559 |
| 84 | MP0000383_abnormal_hair_follicle | 0.80304992 |
| 85 | MP0001663_abnormal_digestive_system | 0.78596606 |
| 86 | MP0001944_abnormal_pancreas_morphology | 0.77962478 |
| 87 | MP0003950_abnormal_plasma_membrane | 0.77657318 |
| 88 | MP0004215_abnormal_myocardial_fiber | 0.76100378 |
| 89 | MP0002152_abnormal_brain_morphology | 0.73894738 |
| 90 | MP0002229_neurodegeneration | 0.73053504 |
| 91 | MP0003303_peritoneal_inflammation | 0.72581248 |
| 92 | MP0002098_abnormal_vibrissa_morphology | 0.71882395 |
| 93 | MP0002184_abnormal_innervation | 0.71300342 |
| 94 | MP0008874_decreased_physiological_sensi | 0.69343367 |
| 95 | MP0005332_abnormal_amino_acid | 0.69310821 |
| 96 | MP0003861_abnormal_nervous_system | 0.64646361 |
| 97 | MP0002752_abnormal_somatic_nervous | 0.64480950 |
| 98 | MP0001270_distended_abdomen | 0.64417562 |
| 99 | MP0002822_catalepsy | 0.63248151 |
| 100 | MP0002882_abnormal_neuron_morphology | 0.62979212 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 5.04825185 |
| 2 | Absent/shortened dynein arms (HP:0200106) | 5.04825185 |
| 3 | Congenital, generalized hypertrichosis (HP:0004540) | 4.57444922 |
| 4 | Diplopia (HP:0000651) | 4.54403120 |
| 5 | Abnormality of binocular vision (HP:0011514) | 4.54403120 |
| 6 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 4.22490743 |
| 7 | Congenital stationary night blindness (HP:0007642) | 4.01351239 |
| 8 | Hemiparesis (HP:0001269) | 3.95740738 |
| 9 | Tubular atrophy (HP:0000092) | 3.74179778 |
| 10 | Abnormal ciliary motility (HP:0012262) | 3.59540021 |
| 11 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.58689085 |
| 12 | Hypotrichosis (HP:0001006) | 3.50110400 |
| 13 | Entropion (HP:0000621) | 3.44716009 |
| 14 | Absent eyebrow (HP:0002223) | 3.44425848 |
| 15 | Poikiloderma (HP:0001029) | 3.42225518 |
| 16 | Abnormal respiratory epithelium morphology (HP:0012253) | 3.29487184 |
| 17 | Abnormal respiratory motile cilium morphology (HP:0005938) | 3.29487184 |
| 18 | Dyskinesia (HP:0100660) | 3.21973928 |
| 19 | Abnormal rod and cone electroretinograms (HP:0008323) | 3.21854691 |
| 20 | Morphological abnormality of the pyramidal tract (HP:0002062) | 3.17540685 |
| 21 | Confusion (HP:0001289) | 3.12212066 |
| 22 | Abnormal respiratory motile cilium physiology (HP:0012261) | 3.04963160 |
| 23 | Ventricular fibrillation (HP:0001663) | 2.99847428 |
| 24 | Limb dystonia (HP:0002451) | 2.98843288 |
| 25 | Curly hair (HP:0002212) | 2.94894548 |
| 26 | Broad-based gait (HP:0002136) | 2.75616639 |
| 27 | Paralysis (HP:0003470) | 2.75379152 |
| 28 | Nonimmune hydrops fetalis (HP:0001790) | 2.73801473 |
| 29 | Palpebral edema (HP:0100540) | 2.66813743 |
| 30 | J-shaped sella turcica (HP:0002680) | 2.65882854 |
| 31 | Inability to walk (HP:0002540) | 2.62955800 |
| 32 | High anterior hairline (HP:0009890) | 2.61744029 |
| 33 | Absent eyelashes (HP:0000561) | 2.56565234 |
| 34 | Partial agenesis of the corpus callosum (HP:0001338) | 2.53761306 |
| 35 | Concave nail (HP:0001598) | 2.51960035 |
| 36 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.51918982 |
| 37 | Abnormality of alanine metabolism (HP:0010916) | 2.51918982 |
| 38 | Hyperalaninemia (HP:0003348) | 2.51918982 |
| 39 | Hypoplastic labia majora (HP:0000059) | 2.46847679 |
| 40 | Genetic anticipation (HP:0003743) | 2.45037607 |
| 41 | Hyperventilation (HP:0002883) | 2.42311639 |
| 42 | Poor eye contact (HP:0000817) | 2.40840676 |
| 43 | Increased number of teeth (HP:0011069) | 2.39017756 |
| 44 | Abnormality of the labia majora (HP:0012881) | 2.36071412 |
| 45 | Gait imbalance (HP:0002141) | 2.35555752 |
| 46 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.34975628 |
| 47 | Pancreatic fibrosis (HP:0100732) | 2.34844716 |
| 48 | Long nose (HP:0003189) | 2.34758145 |
| 49 | Supernumerary spleens (HP:0009799) | 2.34719927 |
| 50 | Spastic paraplegia (HP:0001258) | 2.34672259 |
| 51 | Protruding tongue (HP:0010808) | 2.34238617 |
| 52 | Stomach cancer (HP:0012126) | 2.32100473 |
| 53 | Specific learning disability (HP:0001328) | 2.31617964 |
| 54 | Delayed CNS myelination (HP:0002188) | 2.31613898 |
| 55 | Progressive inability to walk (HP:0002505) | 2.29462138 |
| 56 | Short chin (HP:0000331) | 2.27934898 |
| 57 | Focal motor seizures (HP:0011153) | 2.22939113 |
| 58 | Abnormality of the sella turcica (HP:0002679) | 2.22251906 |
| 59 | Conjugated hyperbilirubinemia (HP:0002908) | 2.18017211 |
| 60 | Abnormal drinking behavior (HP:0030082) | 2.17272387 |
| 61 | Polydipsia (HP:0001959) | 2.17272387 |
| 62 | Birth length less than 3rd percentile (HP:0003561) | 2.17246101 |
| 63 | Absent hair (HP:0002298) | 2.16866311 |
| 64 | Recurrent bronchitis (HP:0002837) | 2.16513775 |
| 65 | Paraplegia (HP:0010550) | 2.15553125 |
| 66 | Nephrogenic diabetes insipidus (HP:0009806) | 2.13589176 |
| 67 | Rib fusion (HP:0000902) | 2.13316719 |
| 68 | Medial flaring of the eyebrow (HP:0010747) | 2.11721288 |
| 69 | Abnormality of DNA repair (HP:0003254) | 2.11371356 |
| 70 | Lymphedema (HP:0001004) | 2.09489234 |
| 71 | Turricephaly (HP:0000262) | 2.09118741 |
| 72 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.09110313 |
| 73 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.09110313 |
| 74 | Cystic hygroma (HP:0000476) | 2.09071277 |
| 75 | Periorbital edema (HP:0100539) | 2.09007727 |
| 76 | Impaired social interactions (HP:0000735) | 2.06122608 |
| 77 | Abnormal social behavior (HP:0012433) | 2.06122608 |
| 78 | Decreased circulating renin level (HP:0003351) | 2.03565561 |
| 79 | Congenital primary aphakia (HP:0007707) | 1.98338754 |
| 80 | Blue irides (HP:0000635) | 1.98153325 |
| 81 | Hypoplastic ischia (HP:0003175) | 1.96983614 |
| 82 | Wide intermamillary distance (HP:0006610) | 1.96283952 |
| 83 | Facial edema (HP:0000282) | 1.96058918 |
| 84 | Pancreatic cysts (HP:0001737) | 1.95847996 |
| 85 | Bronchitis (HP:0012387) | 1.94432709 |
| 86 | Constricted visual fields (HP:0001133) | 1.94399334 |
| 87 | Focal seizures (HP:0007359) | 1.93682684 |
| 88 | Lymphangioma (HP:0100764) | 1.89946291 |
| 89 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.88345018 |
| 90 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.87845079 |
| 91 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.86675210 |
| 92 | Clumsiness (HP:0002312) | 1.84142464 |
| 93 | Epileptic encephalopathy (HP:0200134) | 1.83098059 |
| 94 | Type II lissencephaly (HP:0007260) | 1.80960990 |
| 95 | Generalized tonic-clonic seizures (HP:0002069) | 1.80346112 |
| 96 | Bronchiectasis (HP:0002110) | 1.79951961 |
| 97 | Breast hypoplasia (HP:0003187) | 1.77841415 |
| 98 | Labial hypoplasia (HP:0000066) | 1.77545177 |
| 99 | Heterotopia (HP:0002282) | 1.76338741 |
| 100 | Vertebral arch anomaly (HP:0008438) | 1.74546398 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TSSK6 | 8.71305907 |
| 2 | MAPK15 | 5.98595316 |
| 3 | TIE1 | 4.90376130 |
| 4 | STK16 | 4.36723972 |
| 5 | PNCK | 2.78940678 |
| 6 | WNK4 | 2.57533489 |
| 7 | CASK | 2.22071534 |
| 8 | STK39 | 1.81837415 |
| 9 | MST4 | 1.72948952 |
| 10 | NTRK2 | 1.64083784 |
| 11 | OXSR1 | 1.41049472 |
| 12 | EPHB2 | 1.35475259 |
| 13 | DAPK2 | 1.31696949 |
| 14 | MAP3K2 | 1.26405401 |
| 15 | MAPK13 | 1.20481849 |
| 16 | ACVR1B | 1.16534472 |
| 17 | STK24 | 1.14412797 |
| 18 | GRK1 | 1.12990296 |
| 19 | MAP3K3 | 1.12347128 |
| 20 | CDK3 | 1.11781517 |
| 21 | RPS6KA5 | 1.09348801 |
| 22 | MAPKAPK5 | 1.09180274 |
| 23 | PIM1 | 1.07621521 |
| 24 | BMPR1B | 1.04260061 |
| 25 | MAPKAPK3 | 1.03741245 |
| 26 | PDK2 | 1.02133828 |
| 27 | RPS6KA6 | 1.00038090 |
| 28 | FRK | 0.95984036 |
| 29 | VRK1 | 0.94585561 |
| 30 | PRKCQ | 0.93707824 |
| 31 | CAMK4 | 0.93667900 |
| 32 | DYRK3 | 0.89471801 |
| 33 | NEK9 | 0.87534886 |
| 34 | CDK12 | 0.86684491 |
| 35 | MARK1 | 0.86646095 |
| 36 | IRAK1 | 0.86006308 |
| 37 | MAP3K7 | 0.85497463 |
| 38 | SGK2 | 0.79595213 |
| 39 | EEF2K | 0.79508617 |
| 40 | PIM2 | 0.76928600 |
| 41 | UHMK1 | 0.76861426 |
| 42 | TYRO3 | 0.76471643 |
| 43 | MARK2 | 0.75596571 |
| 44 | SGK223 | 0.74252099 |
| 45 | SGK494 | 0.74252099 |
| 46 | MAP2K2 | 0.73685242 |
| 47 | PKN1 | 0.73461266 |
| 48 | SIK1 | 0.72020460 |
| 49 | PRKCG | 0.64671164 |
| 50 | ADRBK1 | 0.64498521 |
| 51 | MAP4K2 | 0.63797247 |
| 52 | ADRBK2 | 0.61545632 |
| 53 | CAMK2A | 0.59925661 |
| 54 | CSNK1G2 | 0.58732286 |
| 55 | IRAK2 | 0.55438032 |
| 56 | STK38L | 0.55103875 |
| 57 | BCR | 0.53009599 |
| 58 | CAMKK2 | 0.52677731 |
| 59 | DYRK1B | 0.52530887 |
| 60 | ICK | 0.49633370 |
| 61 | PHKG2 | 0.47620750 |
| 62 | PHKG1 | 0.47620750 |
| 63 | SIK2 | 0.46722770 |
| 64 | DYRK1A | 0.45823888 |
| 65 | RPS6KC1 | 0.45281744 |
| 66 | RPS6KL1 | 0.45281744 |
| 67 | WEE1 | 0.44893804 |
| 68 | STK11 | 0.44398572 |
| 69 | PRKD1 | 0.43069364 |
| 70 | RPS6KA1 | 0.42177135 |
| 71 | SGK1 | 0.42021180 |
| 72 | CHUK | 0.41574603 |
| 73 | CAMK1 | 0.40791652 |
| 74 | AKT2 | 0.36607435 |
| 75 | MAP3K4 | 0.36088666 |
| 76 | PLK4 | 0.35777046 |
| 77 | CAMK2G | 0.35593036 |
| 78 | CDK9 | 0.35527965 |
| 79 | PIK3CA | 0.35446588 |
| 80 | MATK | 0.34708531 |
| 81 | NTRK1 | 0.34531474 |
| 82 | RPS6KB1 | 0.34412698 |
| 83 | CAMK2B | 0.34186554 |
| 84 | LMTK2 | 0.33597235 |
| 85 | RPS6KA2 | 0.33583404 |
| 86 | MAPK12 | 0.32709063 |
| 87 | WNK3 | 0.32528445 |
| 88 | IRAK4 | 0.32216530 |
| 89 | SGK3 | 0.31922293 |
| 90 | TEC | 0.29556133 |
| 91 | GSK3A | 0.28967909 |
| 92 | CSNK1G1 | 0.28884870 |
| 93 | MAPK3 | 0.27592711 |
| 94 | MAPK1 | 0.26361491 |
| 95 | RPS6KA3 | 0.26089089 |
| 96 | MAP2K1 | 0.26074775 |
| 97 | INSRR | 0.26069836 |
| 98 | CSNK1G3 | 0.24111912 |
| 99 | CAMK2D | 0.23735709 |
| 100 | CSNK1A1L | 0.23714117 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.59016546 |
| 2 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.81819154 |
| 3 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.64558874 |
| 4 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.60147030 |
| 5 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.59492211 |
| 6 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.48018405 |
| 7 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.38707918 |
| 8 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 2.23266972 |
| 9 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.20360858 |
| 10 | Prion diseases_Homo sapiens_hsa05020 | 2.17909957 |
| 11 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.06754566 |
| 12 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.96877332 |
| 13 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.88825326 |
| 14 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.83455929 |
| 15 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.73916353 |
| 16 | MAPK signaling pathway_Homo sapiens_hsa04010 | 1.68996797 |
| 17 | ABC transporters_Homo sapiens_hsa02010 | 1.66321798 |
| 18 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.53394398 |
| 19 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.53337379 |
| 20 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.39312743 |
| 21 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.35603170 |
| 22 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.34910843 |
| 23 | Cocaine addiction_Homo sapiens_hsa05030 | 1.34838460 |
| 24 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.30979608 |
| 25 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.27755762 |
| 26 | Axon guidance_Homo sapiens_hsa04360 | 1.23978765 |
| 27 | Long-term depression_Homo sapiens_hsa04730 | 1.20980565 |
| 28 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.16470286 |
| 29 | Insulin secretion_Homo sapiens_hsa04911 | 1.15820769 |
| 30 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.15739983 |
| 31 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.12452733 |
| 32 | Circadian entrainment_Homo sapiens_hsa04713 | 1.10644249 |
| 33 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.08271441 |
| 34 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.07932226 |
| 35 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.07305526 |
| 36 | Phototransduction_Homo sapiens_hsa04744 | 1.05767398 |
| 37 | Taste transduction_Homo sapiens_hsa04742 | 1.05474882 |
| 38 | Bile secretion_Homo sapiens_hsa04976 | 1.03546038 |
| 39 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.02959371 |
| 40 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.02328215 |
| 41 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.99896526 |
| 42 | Renin secretion_Homo sapiens_hsa04924 | 0.97846794 |
| 43 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.97432643 |
| 44 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.96570752 |
| 45 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.96169617 |
| 46 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.91961130 |
| 47 | GABAergic synapse_Homo sapiens_hsa04727 | 0.91498382 |
| 48 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.90872994 |
| 49 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.86309992 |
| 50 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.85450633 |
| 51 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.82836836 |
| 52 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.82062762 |
| 53 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.81958774 |
| 54 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.81290412 |
| 55 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.79811470 |
| 56 | Legionellosis_Homo sapiens_hsa05134 | 0.79646428 |
| 57 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.77891959 |
| 58 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.77158843 |
| 59 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.74324338 |
| 60 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.72480995 |
| 61 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.71638997 |
| 62 | Morphine addiction_Homo sapiens_hsa05032 | 0.68283793 |
| 63 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.66679076 |
| 64 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.66296169 |
| 65 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.65364320 |
| 66 | Long-term potentiation_Homo sapiens_hsa04720 | 0.64209622 |
| 67 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.60573282 |
| 68 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.59133489 |
| 69 | Histidine metabolism_Homo sapiens_hsa00340 | 0.58362228 |
| 70 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.58147623 |
| 71 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.57852370 |
| 72 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.56816174 |
| 73 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.53704050 |
| 74 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.49726891 |
| 75 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.49681202 |
| 76 | Olfactory transduction_Homo sapiens_hsa04740 | 0.49066929 |
| 77 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.48126957 |
| 78 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.48080887 |
| 79 | Basal transcription factors_Homo sapiens_hsa03022 | 0.47052171 |
| 80 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.44813657 |
| 81 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.44142318 |
| 82 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.44091880 |
| 83 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.42705761 |
| 84 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.41527017 |
| 85 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.40536619 |
| 86 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.39802280 |
| 87 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.39515923 |
| 88 | Malaria_Homo sapiens_hsa05144 | 0.39094341 |
| 89 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.38632896 |
| 90 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.38182003 |
| 91 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.34738468 |
| 92 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.34655152 |
| 93 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.34546285 |
| 94 | Endometrial cancer_Homo sapiens_hsa05213 | 0.34481784 |
| 95 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.33412305 |
| 96 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.32430234 |
| 97 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.31977238 |
| 98 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.30165306 |
| 99 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.29694701 |
| 100 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.29613170 |

